CTLA4 and ovarian cancer: Accordingly, the epigenetic drugs induced type I interferon (IFN)-related genes, such as IFIs, IFNβ1, IRF7, OASL, and STAT1, in ovarian cancer cells and sensitized them to anti-CTLA4 immunotherapy in a melanoma mouse model [13,15].